Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Prevent, Detect & Treat


 
Pierre Massion, MD

Prevention, early detection and treatment: Those are the three pillars guiding cancer research at Vanderbilt-Ingram Cancer Center where Pierre Massion, MD, who holds the Cornelius Vanderbilt Chair in Medicine and is the Ingram Professor of Cancer Research, has been named to direct VICC's Cancer Early Detection and Prevention Initiative. The focus is directed at expanding campus-wide research and addressing the critical issues in early detection and prevention for a host of leading cancers.


Prevention & Detection of Lung Cancer

"We're trying to make progress in lung cancer management and therapeutics, but people universally recognize that it's difficult to cure cancer," Massion said of the three-pronged mission. "The best chance to have a large impact on the population is through prevention because it's very difficult to move the needle once people already have cancer."

In comparing strategies for detection and intervention of lung cancer, Massion said 12,000 lives a year could be saved through early detection, while 2,500 advanced-stage lung cancer patients could be saved through progress in chemo and targeted therapies.

"The biggest news since 2011 in the field of early detection is that we know screening decreases relative risk for lung cancer mortality by 20 percent," he said. "Many centers are striving to engage in early detection, and Vanderbilt recognized this and wanted to develop an initiative to encourage investigators to study these problems and tackle early detection and prevention, specifically at a cancer center."

A 17-year veteran of Vanderbilt, the pulmonologist stepped in to lead the initiative when it launched in 2016. "This is an exciting, forward-thinking position, and we're trying to readjust disparities in funding and efforts."


Promising Findings at VICC

Massion has dedicated his career to developing strategies for early detection of lung cancer and is driven by the goal of finding better strategies to identify those at greatest risk. In January, his laboratory, in collaboration with researchers in the Schools of Medicine and Engineering at Vanderbilt University, announced discovery of a proteomic "signature" from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

Their findings, reported recently in the journal JCI Insight, are based on the observation that otherwise normal-looking cells in the epithelial lining of the lungs of heavy smokers and others at high risk for lung cancer undergo the same kind of "metabolic reprogramming" as do cancer cells. Massion, who served as senior investigator of the study, said the team was trying to answer the question of why and how cancer cells develop in the airways.

"We wanted to know what molecular changes are happening in the airways of people at different risks, from the young who don't smoke to those at high risk," he said.

The group took brushings of airways (windpipes) to quantify risk of developing lung cancer and methods to identify changes. "Along with increased risk in the airways, people develop a lot of changes in proteins that regulate metabolism into cells," he explained of the findings. "Cells are growing and living in the airways, but as your risk increases and with smoking, some metabolic enzymes get more expressed and specific metabolic pathways change."

Using another method, researchers conducted the same study on a different group of patients at equally low, moderate and high risks. Their results were similar: Cells that look completely normal had undergone profound metabolic changes similar to the changes in cancer cells but without cancer. That discovery led to more questions including how cells update glucose, produce lactate, and deal with oxidized stress and glutamine demand.

"This is relevant because we're closer to understanding how changes in cellular metabolism affect genomic instability," Massion said. "The next step is to understand how metabolic programming facilitates genomic instability, which is a known requirement for the development of cancer."

The findings have resulted in much excitement in the scientific world, as there are proven ways to prevent metabolic changes from happening. "We're interested in understanding how metabolism in the airway affects immune response and how eventually some people develop lung cancer because their immune response was impaired for some reason," Massion said. "A lot revolves around immunology oncology in lung cancer."

Vanderbilt University Medical Center is one of only a few academic medical centers in the country with a dedicated hospital-wide tobacco treatment service (TTS).

Launched in 2015, the Vanderbilt Center for Tobacco, Addiction and Lifestyle (ViTAL) treats an estimated 3,500 patients annually. A tobacco treatment service provides evidence-based care to tobacco users who have been identified from the electronic health record as a current or former smoker. Certified Tobacco Treatment Specialists proactively visit patients to assess use and patterns, as well as to provide counseling and smoking cessation aids to manage nicotine withdrawal. Initiating smoking cessation treatment while a patient is hospitalized has been shown to increase long-term quit rates by 40 percent or higher.

RELATED LINKS:
Vanderbilt-Ingram Cancer Center
VICC Cancer Health Outcomes Control
ViTAL

 
Share:

Related Articles:


Recent Articles

Senators Applaud $25 Million Award to End Modern Slavery

Washington, D.C. (Sept. 14, 2017) ... U.S. Senators Bob Corker (R-Tenn.), Bob Menendez (D-N.J.), Lindsey Graham (R-S.C.), and Ben Cardin (D-Md.) today applauded a $25 million award from the State Department's Office to Monitor and Combat Trafficking in Persons (TIP) for the Global Fund to End Modern Slavery (GFEMS).

Read More

Increasing Number Of Tennesseans Dying From Drug Overdoses

Tennessee Department of Health data show 1,631 Tennesseans died from drug overdoses in 2016, the highest annual number of such deaths recorded in state history. This is an increase from the 1,451 overdose deaths recorded among Tennessee residents in 2015.

Read More

AMA Urges Congress to Take Swift Action to Retain DACA Program Protections

The American Medical Association sent a letter to Congress on Sept. 5 outlining why DACA is an American healthcare issue and urging legislators to take prompt action to ensure individuals with Deferred Action for Childhood Arrivals status are able to remain in the United States.

Read More

New Antiviral Drug Inhibits Epidemic SARS, MERS & More

A multi-institutional team of researchers has found a new antiviral drug candidate that could treat or prevent a number of potential pandemic outbreaks.

Read More

Disaster Preparedness: Are We Ready?

In a world of ever-evolving threats, the officials responsible for a community's health and safety must constantly update, evaluate, prepare and communicate their preparedness plan.

Read More

Addressing Opioid Addiction in America

Even as the AMA works with physicians and other providers to address opioid addiction, the national epidemic continues to evolve.

Read More

Moving Forward on Health Reform

THA's Craig Becker shares the hospital perspective on healthcare reform and what's needed to maintain access to care across Tennessee.

Read More

MGMA Releases 2017 Regulatory Burden Survey: MIPS Tops the List

The results of the Medical Group Management Association (MGMA) 2017 Regulatory Burden Survey reveal there is no shortage of opportunity to reduce regulatory burdens on physician practices.

Read More

In Case of Emergency

On Sept. 8, 2016 the final rule Emergency Preparedness Requirements for Medicare and Medicaid Participating Providers and Suppliers was published in the Federal Register. By Nov. 16, 2017, providers and suppliers must be in compliance.

Read More

Innovative Meharry Program Helps Mothers with Opioid Addiction

The Rainbow Program at Meharry offers pregnant and postpartum women with substance abuse disorders new hope.

Read More

Email Print
 
 

 

 


Tags:
MD, Pierre Massion, Prevention and Lifestyle, Vanderbilt Center for Tobacco Addiction, Vanderbilt Ingram Cancer Center, VICC Cancer Early Detection and Prevention Initiative
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: